Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

Acalabrutinib + R-CHOP standard of care

Mantle-cell Lymphoma

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment55
Primary completion2029-06-30
Primary endpointBest Overall Response Rate (ORR)
Registry IDNCT07029737

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:32:48.203Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07029737

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
Acalabrutinib + R-CHOP standard of care — trial | AEaH